IDEAYA Biosciences Initiates Clinical Trial for New Drug to Address Solid Tumors and Cancer Drug Resistance
IDEAYA Biosciences, Inc., a precision medicine oncology company in the United States, announced that...
World's First! China's Radiomedicine's Nuclear Drug 99mTc-3PRGD2 Broad-Spectrum Tumor Imaging Agent Approved for Market Launch
On April 2, 2026, the China National Medical Products Administration approved the market launch of T...
Thermo Fisher Scientific and SHL Medical Advance Integrated Drug-Device Manufacturing in Ridgefield, New Jersey, USA
Thermo Fisher Scientific and SHL Medical announced a strategic collaboration, while expanding the st...
Vetter Invests in Building an Injectable Drug Production Base in Saarland, Germany
Vetter, a pharmaceutical service provider specializing in injectable drug manufacturing, recently an...
Boehringer Ingelheim Announces Phase II Trial Results for Innovative Drug Apecotrep
German family-owned pharmaceutical company Boehringer Ingelheim today announced the results of the P...
GSK and Noetik Partner to Accelerate Oncology Drug Development
Artificial intelligence-based biotechnology company Noetik announced a five-year strategic collabora...
Osaikang Pharma and Adlai Nortye Enter into License Agreement for Type 1 Innovative Drug AN9025 Project
Wedoany.com Report-Dec.30, Osaikang announced that its subsidiary Jiangsu Osaikang Pharmaceutical Co...
US Health Agency Unveils Weight-Loss Drug Coverage Model
Wedoany.com Report-Dec.24, The U.S. Centers for Medicare and Medicaid Services announced a voluntary...
GSK to Lower Drug Prices
Wedoany.com Report-Dec.22, GSK plc has concluded an agreement with the United States government to r...
Novartis, US Government Reach Agreement to Lower Drug Prices
Wedoany.com Report-Dec.22, Novartis has entered into an agreement with the United States government ...